8-K//Current report
Xenon Pharmaceuticals Inc. 8-K
Accession 0000950170-25-082494
$XENECIK 0001582313operating
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:07 PM ET
Size
239.4 KB
Accession
0000950170-25-082494
Documents
- 8-Kxene-20250604.htmPrimary
8-K
- EX-101.SCHxene-20250604.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-082494-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLxene-20250604_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001582313
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:07 PM ET
- Size
- 239.4 KB